Andujar, Judia Mae S.
HRN: 23-79-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2023
AMPICILLIN 1GM (VIAL)
10/30/2023
11/06/2023
IVT
2gm
Q6h
PROM X 3 Hours
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes